High glucose inhibits receptor activator of nuclear factorκB ligand-induced osteoclast differentiation via downregulation of vATPase V0 subunit d2 and dendritic cellspecific transmembrane protein

Publisher： Spandidos Publications

E-ISSN： 1791-3004|11|2|865-870

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.11, Iss.2, 2015-01, pp. : 865-870

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factorκB ligand in osteoblasts in vivo and in vitro

By          

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 769-777

Spandidos Publications

Access to resources Recommend Favorite

Amiloride inhibits osteoclastogenesis by suppressing nuclear factor-κB and mitogen-activated protein kinase activity in receptor activator of nuclear factor-κB-induced RAW264.7 cells

By                

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3451-3456

Spandidos Publications

Access to resources Recommend Favorite

Transmembrane protein with unknown function 16A overexpression promotes glioma formation through the nuclear factorκB signaling pathway

By          

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 1068-1074

Spandidos Publications

Access to resources Recommend Favorite

Propyl gallate inhibits TPAinduced inflammation via the nuclear factorκB pathway in human THP1 monocytes

By          

Experimental and Therapeutic Medicine, Vol. 5, Iss. 3, 2013-01 ,pp. : 964-968

Spandidos Publications

Access to resources Recommend Favorite

Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (Review)

By    

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3212-3218

Spandidos Publications

Access to resources Recommend Favorite